zirconium Zr 89-DFO-starPEG
Term · Oncology and biomedicine · MLC-T-ONC-017691
A radioconjugate containing starPEG, a 4-armed polyethylene glycol (PEG)-based nanodrug carrier moiety, linked, via the chelator desferrioxamine (DFO), to the radioisotope zirconium Zr 89 (Zr89), with potential use as an imaging agent upon positron emission tomography (PET) imaging. Upon administration, starPEG is taken up by tumors due to enhanced permeability and retention (EPR) effect. Upon PET imaging, EPR-mediated tumor uptake and distribution of the nanodrug carrier may be visualized.
| Identifier | MLC-T-ONC-017691 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | (89Zr)DFO-starPEG; 89-Zr-DFO-star polyethylene glycol; 89Zr-labeled DFO-starPEG; Zr89-DFO-starPEG |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017691",
"term": "zirconium Zr 89-DFO-starPEG",
"field": "Oncology and biomedicine",
"definition": "A radioconjugate containing starPEG, a 4-armed polyethylene glycol (PEG)-based nanodrug carrier moiety, linked, via the chelator desferrioxamine (DFO), to the radioisotope zirconium Zr 89 (Zr89), with potential use as an imaging agent upon positron emission tomography (PET) imaging. Upon administration, starPEG is taken up by tumors due to enhanced permeability and retention (EPR) effect. Upon PET imaging, EPR-mediated tumor uptake and distribution of the nanodrug carrier may be visualized.",
"synonyms": [
"(89Zr)DFO-starPEG",
"89-Zr-DFO-star polyethylene glycol",
"89Zr-labeled DFO-starPEG",
"Zr89-DFO-starPEG"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/zirconium-zr-89-dfo-starpeg/"
}
Record 17,667 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.